BDSX
Biodesix IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$155.96M
P/E Ratio
—
EPS
$-3.96
Beta
0.59
52W High
$20.21
52W Low
$5.00
50-Day MA
$13.93
200-Day MA
$10.67
Dividend Yield
—
Profit Margin
-33.30%
Forward P/E
—
PEG Ratio
—
About Biodesix Inc
Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company is headquartered in Boulder, Colorado.
Fundamentals
| Revenue (TTM) | $96.10M |
| Gross Profit (TTM) | $78.47M |
| EBITDA | $-19.67M |
| Operating Margin | -25.80% |
| Return on Equity | -316.50% |
| Return on Assets | -17.50% |
| Revenue/Share (TTM) | $11.80 |
| Book Value | $0.90 |
| Price-to-Book | 17.08 |
| Price-to-Sales (TTM) | 1.62 |
| EV/Revenue | 2.102 |
| EV/EBITDA | -2.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 42.30% |
| Shares Outstanding | $10.36M |
| Float | $4.99M |
| % Insiders | 41.93% |
| % Institutions | 38.75% |
Historical Volatility
HV 10-Day
61.21%
HV 20-Day
59.57%
HV 30-Day
99.00%
HV 60-Day
94.87%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($30.50 target)
5
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026